Aandelen in “Gezondheidstechnologie”
| Aandeel | Datum | Koers | Evolutie |
|---|---|---|---|
Lantern Pharma Inc |
20/12 | 3,145 USD
-2,02% |
-2,02% |
|
Lantheus Holdings Inc |
20/12 | 89,285 USD
-2,89% |
-2,89% |
|
Larimar Therapeutics Inc |
20/12 | 4,010 USD
+0,75% |
+0,75% |
|
Leap Therapeutics Inc |
20/12 | 2,910 USD
+4,68% |
+4,68% |
|
Legend Biotech Corp |
20/12 | 34,080 USD
+0,18% |
+0,18% |
|
Lemaitre Vascular Inc |
20/12 | 92,120 USD
-0,14% |
-0,14% |
|
LENSAR Inc |
20/12 | 7,700 USD
+2,67% |
+2,67% |
|
Lexicon Pharmaceuticals Inc |
20/12 | 0,715 USD
-1,23% |
-1,23% |
|
Lifevantage Corporation |
20/12 | 17,360 USD
-2,09% |
-2,09% |
|
Ligand Pharmaceuticals, Inc. |
20/12 | 114,640 USD
+0,61% |
+0,61% |
|
Lineage Cell Therapeutics Inc |
20/12 | 0,558 USD
+11,16% |
+11,16% |
|
Lipocine Inc |
20/12 | 4,870 USD
+4,06% |
+4,06% |
|
Liquidia Corp |
20/12 | 11,100 USD
+4,82% |
+4,82% |
|
LivaNova PLC |
20/12 | 47,590 USD
+0,21% |
+0,21% |
|
Lixte Biotechnology Holdings Inc |
20/12 | 1,980 USD
+3,66% |
+3,66% |
Lumibird |
20/12 | 8,600 EUR
0,00% |
0,00% |
|
Lumos Pharma Inc |
11/12 | 4,340 USD
0,00% |
0,00% |
|
Lyra Therapeutics Inc |
20/12 | 0,180 USD
+5,88% |
+5,88% |